GABP-α inhibitors belong to a specific chemical class of compounds that exert their biological effects by targeting and modulating the activity of the GABP-α transcription factor. GABP-α, or GA-binding protein alpha, is a crucial transcription factor that plays a central role in regulating the expression of various genes involved in cellular processes such as proliferation, differentiation, and metabolism. Inhibitors of GABP-α are designed to interfere with the binding of this transcription factor to its target DNA sequences, thereby disrupting its ability to activate gene expression. This class of compounds represents a promising area of research in the field of molecular biology due to its ability to manipulate gene expression patterns and impact cellular functions.
The mechanism of action of GABP-α inhibitors typically involves the binding of these compounds to specific regions of the GABP-α protein, often at the DNA-binding domain or other critical interaction sites. By binding to GABP-α, these inhibitors can prevent its interaction with DNA and thereby inhibit the transcriptional activation of target genes. This interference with gene expression can have far-reaching consequences on various cellular pathways, making GABP-α inhibitors valuable tools for understanding the regulatory networks that govern cell behavior. Researchers are actively exploring the development and optimization of GABP-α inhibitors to uncover their full potential in deciphering molecular mechanisms within cells and identifying novel applications in the future.
SEE ALSO...
Items 21 to 22 of 22 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
ATRA is a derivative of vitamin A and affects cellular differentiation and growth. Its potential role in inhibiting GABP-α might be through its effects on transcription regulation and cell cycle control. | ||||||
SCH772984 | 942183-80-4 | sc-473205 | 5 mg | $363.00 | 5 | |
SCH772984 is an ERK inhibitor that prevents the phosphorylation of ERK substrates, thereby disrupting downstream signaling. By inhibiting ERK1/2, SCH772984 indirectly affects the activation of GABP-α, as ERK-mediated phosphorylation is a requirement for the full transcriptional activity of GABP-α. This inhibition reduces the expression of ERK-dependent genes that are co-regulated by GABP-α. | ||||||